At ASM Microbe 2025, Meghan Starolis, PhD, discusses her presentation on antiviral testing including the advantages and limitations to genotypic and phenotypic testing and looking at how this can affect the immunocompromised population.
Meghan Starolis, PhD
Advertisement
Starolis is senior science director of Infectious Diseases at the Quest Diagnostics’ Nichols Institute.
Articles by Meghan Starolis, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
Vaccines as a Secondary Strategy in the Fight Against Antimicrobial Resistance
2
Cefiderocol is Noninferior, But not "Game-Changer," for Gram-negative Bloodstream Infections
3
Misdiagnosis Common in Skin Infections Due to Overlapping Noninfectious Conditions
4
As NDM-CRE Infections Rise Significantly, Diagnostic Access Emerges as Weak Link
5
